Loading…
STXS
Stereotaxis, Inc.
NYSE American· Healthcare· Medical Instruments & Supplies· CUSIP 85916J409
$1.45-1.36%Price as of Aug 29, 18:32 UTC · updated once a day, after the close
Key metrics
- Market cap
- $145.29M
- P/E
- —
- Forward P/E
- —
- P/B
- 11.6x
- Dividend yield
- —
- Payout
- —
- EPS
- -$0.24
- ROE
- -184.27%
- Profit margin
- -74.24%
- Revenue growth
- -12.80%
- Beta
- 1.40
- 52-week high
- $3.59
- 52-week low
- $1.24
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -78.0% over 5Y.
today you would have $241.64▼ -75.8%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 17 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $2.30 | $2.28 | $1.75 | $2.07 | $6.20 | $5.09 | $5.29 | $1.08 | $0.80 | $0.65 | $0.74 | $1.48 | $3.62 | $2.33 | $7.48 | $34.95 | $35.86 | |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| OWLTOwlet, Inc. | $4.99 | — | 6.2x | — | — | $145.82M |
| MISTMilestone Pharmaceuticals Inc. | $1.16 | — | 9.0x | — | -35522.62% | $144.42M |
| NMRANeumora Therapeutics, Inc. | $0.78 | — | 3.3x | — | -187.11% | $146.28M |
| UNCYUnicycive Therapeutics, Inc. | $5.27 |
About the company
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
- 131
- Saint Louis, United States
Company description provided by Yahoo Finance.